Article citationsMore>>
Drosten, C., Gunther, S., Preiser, W., Van der Werf, S., Brodt, H.R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R.A., Berger, A., Burguiere, A.M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.C., Muller, S., Rickerts, V., Sturmer, M., Vieth, H., Klenk, D.S., Osterhaus, A.D., Schmitz, H. and Doerr, H.W. (2003) Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. The New England Journal of Medicine, 348, 1967-1976.
https://doi.org/10.1056/NEJMoa030747
has been cited by the following article:
-
TITLE:
Biological Disruptive Therapies as Counter Measures for Unpredictable Biological Insults, a Case for Successful Treatment of COVID-19
AUTHORS:
Mohammad Nezami, Vicky Yamamoto
KEYWORDS:
COVID-19, Acute Respiratory Distress Syndrome(ARDS), Phosphoinositol 3 Kinase (Pi3K), Quercetin
JOURNAL NAME:
Advances in Infectious Diseases,
Vol.10 No.3,
September
14,
2020
ABSTRACT: Treatment of patients with severe COVID-19, is challenging specifically when a patient carries high risk of mortality, such as old age, immune suppression or cancer. Also a patient who manifests the disease with severe symptoms, such as hypoxia, requiring supplemental oxygenation, or artificial ventilation has a poor prognosis. Here we review the scientific rationale used to design a very promising therapy based on existing literature, but in significantly different method and protocols, used to treat cases of severe COVID-19, and we conclude that although the effort on drug development has been enormous, but as of today, we do not have a therapy with specific characteristics as this protocol, to be used safely in human and yet potentially meet the expectations we would have for a so called “effective therapy”. Further clinical trials are needed to support this hypothesis and generate further hypothesis to prove the concept in larger cohort of patients.
Related Articles:
-
Andrew Beckwith
-
Casimir Komenan
-
Byeong-Sam Kim, Kyoungwoo Park, Young-Woo Kim
-
Mohamed S. El Naschie
-
Huu S. Tieu, Martin F. Loeffler